AVPT tore higher this week on the back of its Q1 results, putting the stock at the centre of one of the sharpest post-earnings moves in the application software space.
The earnings beat drove a 10.5% single-day jump on May 8, extending the week's total gain to nearly 12% and lifting the stock to $11.40. That recovery is meaningful in context: AvePoint is still down roughly 18% year-to-date, so the week's move represents a significant reclaim of ground lost since January. The next quarterly report lands August 6 — roughly three months of runway to consolidate before the Street gets another hard data point.
Options markets captured the sentiment shift cleanly. The put/call ratio dropped to 0.10 on May 8, almost two standard deviations below its 20-day average of 0.14 — one of the most call-skewed readings of the past year, with the 52-week low sitting at just 0.02. Investors piled into upside exposure rather than protection, a sharp reversal from the slightly more cautious tone that had prevailed through April when the PCR was running closer to 0.16. An RSI of 68 reinforces the near-term momentum.
Short positioning, already modest, moved further out of the way ahead of results. Short Interest % of FF came in at 5.1% as of May 7 — down from around 5.9% a month ago, and well below the mid-April level when shorts briefly pushed above 12.6 million shares during the broader market selloff in early April. Days to cover via FINRA data is 7.4, reflecting a relatively illiquid float, but availability in the lending market remains loose, with only around 1.6% of the available pool currently lent out. Cost to borrow ticked up 42% on the week to 0.32% — a notable percentage move but a level that still imposes no real friction on new short positions.
The Street's reaction to the print told a nuanced story. Scotiabank moved fastest, lowering its target from $13 to $12 within hours of results while holding its Sector Outperform rating — signalling that while the beat was real, the prior targets embedded more optimism than the current setup justifies. The broader analyst community has been in target-trimming mode since February, with cuts from Evercore, Cantor Fitzgerald, Jefferies, and TD Cowen all pulling forecasts lower in the wake of Q4. The consensus mean target now sits at $16.31, implying 43% upside from current levels — a gap wide enough to keep the buy-side interested even after target reductions. The P/E is 24.9x, EV/EBITDA around 15.5x, and the company carries net cash of $557 million, providing a balance-sheet cushion that limits downside in weaker macro scenarios.
Institutionally, the register has a concentrated ownership structure that warrants attention. Singapore sovereign fund Temasek holds 9.2%, Vanguard 8.1%, and co-founders Tianyi Jiang and Xunkai Gong together own roughly 15% between them — both added shares as recently as March. BlackRock added 825,000 shares through April, and State Street added 300,000. On the other side, a cluster of small insider sells took place in mid-March — CEO, CFO, Executive Chairman, and General Counsel all sold minor positions at around $10.30. The volumes were tiny relative to their total holdings and carried low trade-significance scores, consistent with routine vesting-related activity rather than conviction selling.
What to watch next: whether this week's move holds or fades will depend on how the Street digests the guidance embedded in the Q1 release — specifically whether the revenue growth trajectory and expanding operating cash flow ($110 million on a trailing basis) are enough to pull analyst targets back toward previous levels, or whether Scotiabank's cut foreshadows further reductions across the coverage group.
See the live data behind this article on ORTEX.
Open AVPT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
